Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks of nausea, vomiting, and diarrhea. High-quality evidence ...

Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health. About 1 in 8 U.S. adults say they are taking a GLP-1 drug ...

What to do—and what not to do. If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight-loss ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

Eli Lilly now has FDA approval for its GLP-1 obesity pill, introducing a convenient dosing alternative to injections and new competition to a Novo Nordisk weight loss pill that has experienced strong ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Food and Drug Administration has approved Foundayo, Eli Lilly’s new GLP-1 pill to treat ...

Studies show tirzepatide leads to significantly more weight loss on average compared to semaglutide. Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type ...

A recent op-ed in the Washington Post describes the story of an author who decided he wanted to lose weight. Although he was healthy, he heard from friends how easy and effective GLP-1 medications ...

GLP-1 medications showed a range of potential benefits and safety concerns in an umbrella review of non-cardiometabolic outcomes, though the data quality for many remained limited. Across 60 ...

Amazon Pharmacy has begun offering Eli Lilly’s GLP-1 medication, Foundayo, via same-day delivery. The once-daily oral treatment is approved for adults with obesity or overweight with weight-related ...